Celldex therapeutics, inc. (CLDX)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash Flows From Operating Activities:
Net Loss

-46,264

-50,878

-49,834

-45,664

-50,291

-151,184

-145,622

-164,742

-176,902

-93,031

-121,497

-124,732

-128,118

-128,530

-128,907

-131,289

-131,696

-127,197

-126,335

-122,436

-118,351

-118,080

-108,320

-103,379

-94,121

-81,550

-76,295

-68,182

-62,939

-59,123

-55,048

-51,793

-48,256

-44,799

0

0

0

Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Depreciation and Amortization

0

-

-

-

0

-

-

-

4,076

4,414

4,352

4,028

3,719

3,095

2,982

3,048

3,068

2,998

2,775

2,611

2,481

2,388

2,274

2,150

2,043

1,932

1,893

1,917

1,971

2,047

2,128

2,191

2,230

2,248

0

0

0

Amortization of Intangible Assets

-

-

-

-

-

224

448

672

896

896

909

938

968

997

1,013

1,013

1,013

1,013

1,013

1,013

1,013

1,013

1,013

1,013

1,013

1,013

1,014

1,014

1,052

1,090

1,127

1,530

1,721

1,913

0

0

0

Amortization and Premium of Marketable Securities, Net

858

1,140

1,362

1,320

1,238

1,048

785

509

422

290

13

-153

-374

-926

-1,619

-2,190

-2,098

-350

-348

-303

-1,005

-95

888

853

2,526

1,366

1,472

2,452

1,256

660

307

-102

600

-17

0

0

0

Realized Gain on Sales and Maturities of Marketable Securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6

6

9

4

-5

0

0

0

Loss on Sale or Disposal of Assets

-

-11

-57

-158

-1,235

-1,220

0

0

0

-

-

-

-

-81

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

74

74

15

-20

58

0

0

0

Goodwill Impairment

-

-

-

-

-

90,976

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible Asset Impairment

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other Asset Impairment

-

1,800

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on Fair Value Remeasurement of Contingent Consideration

2,579

1,294

3,265

8,086

14,502

29,621

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on Fair Value Remeasurement of Contingent Consideration

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-Cash Income Tax Benefit

-

-

-

-

-

-765

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-Based Compensation Expense

3,545

4,551

5,616

6,702

7,286

8,081

8,913

9,859

11,261

12,312

13,336

14,393

14,916

15,317

15,806

15,879

14,433

12,774

10,810

8,899

7,883

6,852

5,867

5,925

5,090

4,548

4,084

2,594

2,365

2,298

2,253

2,297

2,403

2,342

0

0

0

Non-Cash Expense

-

-

-

-

-

-

-

-

-

-

-

-

-

1,638

1,710

1,782

1,854

288

0

0

0

-

-

-

-

97

154

212

225

226

226

226

229

307

0

0

0

Changes in Operating Assets and Liabilities:
Accounts and Other Receivables

-1,326

-2,274

-2,448

-1,928

-1,713

777

-343

1,234

2,131

96

1,434

243

537

814

1,052

682

168

543

-2,378

-91

374

-62

2,015

513

201

445

858

-49

-36

-126

-172

-102

-103

-154

0

0

0

Prepaid and Other Current Assets

-269

-362

-446

-845

-2,226

-1,783

-1,813

-2,105

-1,638

-793

-2,170

-3,933

-2,072

-1,320

500

1,940

2,356

653

1,076

2,038

1,013

2,026

677

2,107

523

706

1,416

-102

529

-33

-175

-156

269

-241

0

0

0

Other Assets

-

-

-

-

-

-

-

-

-

-205

0

0

0

-

-

-

-

-6

-22

65

117

-65

-58

-58

-104

-276

-252

-254

-224

95

61

61

60

-34

0

0

0

Accounts Payable and Accrued Expenses

281

-321

-4,748

-8,813

-8,646

-13,110

-7,102

-7,827

-6,348

-8,744

-4,298

-1,570

-8,328

-4,970

-6,615

-7,861

3,138

4,875

2,120

5,007

-101

1,450

3,542

6,094

5,361

7,236

5,221

4,864

5,017

3,762

3,015

2,020

1,956

2,076

0

0

0

Other Liabilities

-5,630

-6,599

-6,437

-5,704

-3,930

-3,268

-3,742

-4,194

-4,636

-4,363

-1,940

-1,770

-1,983

-2,007

7,438

7,414

7,174

7,202

295

247

5,184

6,577

4,877

6,470

1,396

1,317

1,406

183

504

594

574

313

180

-138

0

0

0

Net Cash Used in Operating Activities

-45,292

-46,415

-50,845

-54,093

-60,446

-75,235

-79,326

-89,299

-92,691

-99,931

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Cash Used in Operating Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-101,200

-

-107,356

-106,157

-102,251

-101,537

-94,280

-85,142

-82,344

-67,669

-66,038

-59,528

-53,429

-49,782

-45,826

-42,941

-40,347

-35,658

0

0

0

Cash Flows From Investing Activities:
Sales and Maturities of Marketable Securities

97,487

113,173

114,607

162,673

192,484

201,469

213,888

173,948

192,371

219,236

231,560

244,895

241,589

242,792

226,656

224,112

178,962

161,090

149,366

144,990

135,016

109,232

97,430

68,899

62,783

38,894

37,607

52,023

53,842

52,360

58,082

53,528

48,262

51,003

0

0

0

Purchases of Marketable Securities

-

95,382

96,635

152,845

161,469

171,182

200,303

155,913

151,136

170,980

146,283

145,841

176,026

173,925

162,467

162,024

134,724

206,405

195,970

186,526

156,439

148,314

165,877

149,495

170,725

112,118

103,755

118,717

89,676

69,255

62,400

53,373

82,860

52,717

0

0

0

Acquisition of Property and Equipment

780

731

788

706

740

813

841

1,063

1,673

1,788

2,236

2,760

2,585

2,751

2,520

3,075

3,855

4,876

4,632

3,943

3,295

1,929

4,084

4,396

4,252

4,219

2,011

1,098

423

303

299

349

349

509

0

0

0

Proceeds from Sale or Disposal of Assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

218

218

160

15

68

0

0

0

Net Cash Provided by Investing Activities

22,749

17,080

17,204

9,464

30,617

29,816

13,086

16,972

39,562

46,468

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Cash Provided by Investing Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,383

-

-51,236

-45,479

-24,718

-41,011

-72,531

-84,992

-112,173

-77,422

-68,138

-67,709

-36,050

-16,980

-4,399

-34

-34,932

-2,155

0

0

0

Cash Flows From Financing Activities:
Net Proceeds from Stock Issuances

13,710

16,248

17,395

20,425

21,484

29,022

43,836

49,496

49,893

51,025

0

0

0

-

-

-

-

188,840

0

0

0

-

-

-

-

295,697

135,099

146,014

146,042

83,784

0

0

0

-

-

-

-

Proceeds from Issuance of Stock from Employee Benefit Plans

24

9

9

54

54

419

492

563

563

265

196

263

332

536

850

1,403

1,606

4,311

4,004

3,572

3,454

1,171

3,632

3,965

4,445

5,403

0

0

0

-

-

-

-

-

-

-

-

Net Cash Provided by Financing Activities

13,734

16,257

17,404

20,479

21,538

29,441

44,328

50,059

50,456

51,290

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of Term Loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,029

0

0

0

-

-

-

-

-

-

-

-

(Payments) Issuance of Term Loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,000

0

0

0

Payment of Convertible Subordinated Debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,503

0

0

0

Payments of Other Liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

472

58

55

55

55

55

57

55

86

0

0

0

Net Cash Provided by Financing Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,672

-

192,844

192,412

192,228

1,171

184,714

185,032

175,792

289,599

125,618

134,576

142,353

79,758

60,314

50,711

87,897

28,434

0

0

0

Effect of Exchange Rate Changes on Cash and Cash Equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

14

11

9

-5

-4

-1

0

-3

-3

-2

-2

2

1

-3

-3

-9

0

0

0

Net Decrease in Cash and Cash Equivalents

-

-

-

-

-

-

-

-

-2,673

-2,173

22,992

33,680

-20,528

-29,647

-35,048

-49,102

-59,145

44,088

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Decrease in Cash and Cash Equivalents

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Increase (Decrease) in Cash and Cash Equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-8,561

7,337

52,872

12,998

10,090

7,733

12,615

-9,388

0

0

0

Non-cash Investing Activities
Acquisition of Property and Equipment Included in Accounts Payable and Accrued Expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued construction in progress

0

-

-

0

0

-

-

-

-138

20

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash Supplemental Disclosure
Shares issued to former Kolltan executive for settlement of severance

-

-

-

-

-

71

107

138

173

344

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-